Liver Cancer & Liver Metastases | NYU Langone Health
Experts at NYU Langone’s Perlmutter Cancer Center diagnose and treat people who have liver cancer and liver metastases.
Liver Care & Transplant Program | NYU Langone Health
Experts at NYU Langone’s Liver Care and Transplant Program provide screening, diagnosis, and treatment of liver diseases and liver cancer.
Liver Care & Transplant Program Doctors | NYU Langone Health
Find a doctor at the Liver Care & Transplant Program at NYU Langone.
Liver Transplant Program | NYU Langone Health
NYU Langone Transplant Institute’s doctors offer specialized liver transplant care and other types of liver surgery for adults and children.
Liver Transplant Program Doctors | NYU Langone Health
Find a doctor at the Liver Transplant Program at NYU Langone.
Liver Tumor Program | NYU Langone Health
Liver Tumor Program specialists at NYU Langone’s Perlmutter Cancer Center provide treatment for liver, biliary tract, and gallbladder tumors.
LLF001: Endpoint Enabling Study in Cyclin-dependent kinase-like 5 Deficiency Disorder (CDD)
This study will prospectively follow individuals with confirmed CDDover the course of 3 years. Enrollment will occur on a rolling basis.Study procedures will include in-clinic evaluations at baseline, 6, 12,18, 24 and 36 months and remote assessments at 3, 9 and 30 months.
Local Therapies for Kaposi Sarcoma | NYU Langone Health
NYU Langone doctors may use local therapies to manage a few Kaposi sarcoma lesions on the skin or in the mouth.
Locations Directory | NYU Langone Health
View our directory of NYU Langone locations across the New York City area and in Florida, and find locations by borough and neighborhood.
Locus-coeruleus function in normal elderly and AD risk (LEAD)
Growing evidence suggests that Alzheimer’s disease (AD) pathological changes begin decades before clinical symptoms and tau abnormalities in the locus coeruleus (LC) can be observed since midlife. We have previously demonstrated functional vulnerability of the LC to aging and stress, as well as an association between higher CSF tau and impaired sleep phenomena influenced by the LC. We now aim to test whether LC dysfunction can be measured in preclinical AD stages by LC targeted imaging, and whether it objectively affects sleep architecture and attention; by asking 30 cognitively normal older adults to perform a full clinical evaluation, one night of polysomnography, a lumbar puncture (LP) to obtain cerebrospinal fluid, [11C]MRB PET-MR, as well as attention testing.